CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Ibuprofen versus Indomethacin for the Closure of Patent Ductus Arteriosus in Neonates: Comparative Effectiveness

Last updated: September 9, 2008
Product Line: Rapid Response
Research Type: Drug
Result type: Report

Question

  1. What is the comparative effectiveness of ibuprofen versus indomethacin for the closure of patent ductus arteriosus in neonates?